The effects of thiol modifiers on the activation of NF kappa B by interleukin-1.
Brennan
P
P
Biochemistry Department, Trinity College, Dublin, Ireland.
Bowie
A
A
O'Neill
L A
LA
D000111:Acetylcysteine / Q000494:pharmacology*; D000818:Animals; D002460:Cell Line; D002467:Cell Nucleus / Q000187:drug effects / Q000378:metabolism; D003958:Diamide / Q000494:pharmacology; D004137:Dinitrochlorobenzene / Q000494:pharmacology; D004976:Ethacrynic Acid / Q000494:pharmacology; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology; D007375:Interleukin-1 / Q000494:pharmacology*; D051379:Mice; D016328:NF-kappa B / Q000378:metabolism*; D013439:Sulfhydryl Reagents / Q000494:pharmacology*; D013601:T-Lymphocytes / Q000187:drug effects / Q000378:metabolism*; D013945:Thymoma; D013953:Thymus Neoplasms; D014407:Tumor Cells, Cultured
D004137:Dinitrochlorobenzene; D007375:Interleukin-1; D016328:NF-kappa B; D013439:Sulfhydryl Reagents; D003958:Diamide; D006861:Hydrogen Peroxide; D004976:Ethacrynic Acid; D000111:Acetylcysteine